Skip to main content
. 2015 Apr-Jun;6(2):58–64. doi: 10.4103/2231-4040.154531

Figure 2.

Figure 2

In vitro drug release profiles of nanoparticle formulations containing low molecular weight heparin prepared using different concentrations of polylactide co-glycolide 85:15 (150, 200 mg) and different concentrations of surfactant (0.1%, 0.5%, 1%)